Response to the letter by Prof Jonathan Deeks to the Lancet EClinicalMedicine editor

Documents similaires

• Corrigendum to ‘Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study.’ [EClinicalMedicine 59 (2023) 101981]
  par: Yuming Sun, et autres
  Publié: (2023-08-01)
• Corrigendum to “Real-world long-term outcomes in individuals at clinical risk for psychosis: The case for extending duration of care” [EClinicalMedicine 28 (2020) 100,578]
  par: Paolo Fusar-Poli, et autres
  Publié: (2021-02-01)
• Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981]
  par: Vinicius Fontanesi Blum, MD, MSc, et autres
  Publié: (2021-11-01)
• Addendum to ‘A comparison of electronically-delivered and face to face cognitive behavioural therapies in depressive disorders: A systematic review and meta-analysis’ [EClinicalMedicine 24 (2020) 100442]
  par: Candice Luo, et autres
  Publié: (2020-10-01)
• Corrigendum to “Sex differences in HIV treatment outcomes and adherence by exposure groups among adults in Guangdong, China: A retrospective observational cohort study” [EClinicalMedicine 22 (2020) 100351]
  par: Linghua Li, et autres
  Publié: (2020-12-01)